David Driscoll to Fatty Acids, Omega-3
This is a "connection" page, showing publications David Driscoll has written about Fatty Acids, Omega-3.
Connection Strength
3.030
-
Driscoll DF, Bistrian BR. Cytokine Release Syndrome Associated With Immune-Modulating Chemotherapy: Potential Mitigating Role of Intravenous Omega-3 Fatty Acid Triglycerides. Cancer Rep (Hoboken). 2024 Oct; 7(10):e70025.
Score: 0.898
-
Driscoll DF, Bistrian BR. Cytokine storm associated with severe COVID-19 infections: The potential mitigating role of omega-3 fatty acid triglycerides in the ICU. FASEB J. 2023 08; 37(8):e23066.
Score: 0.828
-
Welty F, Bistrian B, Driscoll D. Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk. JAMA. 2021 04 06; 325(13):1333.
Score: 0.705
-
Driscoll DF, Ling PR, Bistrian BR. Pharmacopeial compliance of fish oil-containing parenteral lipid emulsion mixtures: Globule size distribution (GSD) and fatty acid analyses. Int J Pharm. 2009 Sep 08; 379(1):125-30.
Score: 0.311
-
Driscoll DF. Lipid injectable emulsions: 2006. Nutr Clin Pract. 2006 Aug; 21(4):381-6.
Score: 0.255
-
Bonaterra GA, Driscoll D, Schwarzbach H, Kinscherf R. Krill Oil-In-Water Emulsion Protects against Lipopolysaccharide-Induced Proinflammatory Activation of Macrophages In Vitro. Mar Drugs. 2017 Mar 15; 15(3).
Score: 0.033